nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—ABCB1—Topotecan—cervical cancer	0.117	0.625	CbGbCtD
Doxepin—CYP3A4—Topotecan—cervical cancer	0.0699	0.375	CbGbCtD
Doxepin—CHRM3—ureter—cervical cancer	0.0546	0.165	CbGeAlD
Doxepin—CHRM3—exocrine gland—cervical cancer	0.0108	0.0325	CbGeAlD
Doxepin—CHRM5—epithelium—cervical cancer	0.00838	0.0253	CbGeAlD
Doxepin—ADRA1D—epithelium—cervical cancer	0.00749	0.0226	CbGeAlD
Doxepin—ADRA1B—renal system—cervical cancer	0.0071	0.0214	CbGeAlD
Doxepin—Hyperbilirubinaemia—Topotecan—cervical cancer	0.00656	0.0392	CcSEcCtD
Doxepin—Dysmenorrhoea—Topotecan—cervical cancer	0.00656	0.0392	CcSEcCtD
Doxepin—ADRA1D—female reproductive system—cervical cancer	0.00556	0.0168	CbGeAlD
Doxepin—ORM1—endometrium—cervical cancer	0.00553	0.0167	CbGeAlD
Doxepin—Neoplasm—Topotecan—cervical cancer	0.00539	0.0322	CcSEcCtD
Doxepin—HTR2B—uterine cervix—cervical cancer	0.00516	0.0156	CbGeAlD
Doxepin—Ear pain—Topotecan—cervical cancer	0.00507	0.0303	CcSEcCtD
Doxepin—HTR2B—decidua—cervical cancer	0.00492	0.0148	CbGeAlD
Doxepin—HTR2B—endometrium—cervical cancer	0.00467	0.0141	CbGeAlD
Doxepin—ORM1—female reproductive system—cervical cancer	0.00458	0.0138	CbGeAlD
Doxepin—Lethargy—Topotecan—cervical cancer	0.00442	0.0264	CcSEcCtD
Doxepin—SLC6A2—decidua—cervical cancer	0.00437	0.0132	CbGeAlD
Doxepin—CHRM3—renal system—cervical cancer	0.00434	0.0131	CbGeAlD
Doxepin—HTR1A—renal system—cervical cancer	0.00433	0.0131	CbGeAlD
Doxepin—HTR2B—uterus—cervical cancer	0.0043	0.013	CbGeAlD
Doxepin—ADRA1A—epithelium—cervical cancer	0.0043	0.013	CbGeAlD
Doxepin—KCNH2—uterine cervix—cervical cancer	0.00412	0.0124	CbGeAlD
Doxepin—HTR2C—female reproductive system—cervical cancer	0.00412	0.0124	CbGeAlD
Doxepin—ADRA2C—uterine cervix—cervical cancer	0.00406	0.0123	CbGeAlD
Doxepin—ADRA1A—renal system—cervical cancer	0.00399	0.012	CbGeAlD
Doxepin—SLC6A4—female reproductive system—cervical cancer	0.0039	0.0118	CbGeAlD
Doxepin—Cramp muscle—Topotecan—cervical cancer	0.0039	0.0233	CcSEcCtD
Doxepin—CHRM1—female reproductive system—cervical cancer	0.00389	0.0117	CbGeAlD
Doxepin—ADRA2C—decidua—cervical cancer	0.00387	0.0117	CbGeAlD
Doxepin—HTR2B—female reproductive system—cervical cancer	0.00387	0.0117	CbGeAlD
Doxepin—KCNH2—renal system—cervical cancer	0.00385	0.0116	CbGeAlD
Doxepin—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00382	0.0228	CcSEcCtD
Doxepin—HRH2—lymph node—cervical cancer	0.00381	0.0115	CbGeAlD
Doxepin—ADRA2C—renal system—cervical cancer	0.0038	0.0115	CbGeAlD
Doxepin—KCNH2—endometrium—cervical cancer	0.00372	0.0112	CbGeAlD
Doxepin—ADRA2C—endometrium—cervical cancer	0.00367	0.0111	CbGeAlD
Doxepin—ADRA2C—mammalian vulva—cervical cancer	0.00355	0.0107	CbGeAlD
Doxepin—Pancytopenia—Topotecan—cervical cancer	0.00355	0.0212	CcSEcCtD
Doxepin—HTR2B—vagina—cervical cancer	0.0035	0.0105	CbGeAlD
Doxepin—CHRM3—female reproductive system—cervical cancer	0.00348	0.0105	CbGeAlD
Doxepin—SLC6A2—female reproductive system—cervical cancer	0.00344	0.0104	CbGeAlD
Doxepin—KCNH2—uterus—cervical cancer	0.00343	0.0104	CbGeAlD
Doxepin—Weight increased—Topotecan—cervical cancer	0.00341	0.0203	CcSEcCtD
Doxepin—ADRA2C—uterus—cervical cancer	0.00339	0.0102	CbGeAlD
Doxepin—Pneumonia—Topotecan—cervical cancer	0.00336	0.0201	CcSEcCtD
Doxepin—Infestation—Topotecan—cervical cancer	0.00334	0.0199	CcSEcCtD
Doxepin—Infestation NOS—Topotecan—cervical cancer	0.00334	0.0199	CcSEcCtD
Doxepin—HRH1—epithelium—cervical cancer	0.00333	0.01	CbGeAlD
Doxepin—HRH1—uterine cervix—cervical cancer	0.0033	0.00995	CbGeAlD
Doxepin—CYP1A2—renal system—cervical cancer	0.0033	0.00995	CbGeAlD
Doxepin—Neuropathy peripheral—Topotecan—cervical cancer	0.00327	0.0195	CcSEcCtD
Doxepin—Stomatitis—Topotecan—cervical cancer	0.00325	0.0194	CcSEcCtD
Doxepin—ADRA2A—uterine cervix—cervical cancer	0.00324	0.00978	CbGeAlD
Doxepin—Sweating—Topotecan—cervical cancer	0.0032	0.0191	CcSEcCtD
Doxepin—CHRM3—female gonad—cervical cancer	0.00317	0.00955	CbGeAlD
Doxepin—Hepatobiliary disease—Topotecan—cervical cancer	0.00316	0.0189	CcSEcCtD
Doxepin—HRH1—decidua—cervical cancer	0.00314	0.00948	CbGeAlD
Doxepin—ADRA2A—decidua—cervical cancer	0.00309	0.00932	CbGeAlD
Doxepin—KCNH2—female reproductive system—cervical cancer	0.00309	0.00931	CbGeAlD
Doxepin—HRH1—endometrium—cervical cancer	0.00299	0.009	CbGeAlD
Doxepin—Hypoaesthesia—Topotecan—cervical cancer	0.00298	0.0178	CcSEcCtD
Doxepin—Pharyngitis—Topotecan—cervical cancer	0.00297	0.0178	CcSEcCtD
Doxepin—ADRA2A—endometrium—cervical cancer	0.00293	0.00884	CbGeAlD
Doxepin—CYP2C19—vagina—cervical cancer	0.00292	0.00882	CbGeAlD
Doxepin—HRH1—mammalian vulva—cervical cancer	0.00289	0.00871	CbGeAlD
Doxepin—ADRA2A—mammalian vulva—cervical cancer	0.00284	0.00855	CbGeAlD
Doxepin—KCNH2—female gonad—cervical cancer	0.00281	0.00847	CbGeAlD
Doxepin—KCNH2—vagina—cervical cancer	0.00279	0.00842	CbGeAlD
Doxepin—HTR2A—epithelium—cervical cancer	0.00278	0.00839	CbGeAlD
Doxepin—ADRA2C—female gonad—cervical cancer	0.00277	0.00835	CbGeAlD
Doxepin—ADRA2C—vagina—cervical cancer	0.00275	0.0083	CbGeAlD
Doxepin—Angiopathy—Topotecan—cervical cancer	0.00272	0.0162	CcSEcCtD
Doxepin—Immune system disorder—Topotecan—cervical cancer	0.00271	0.0162	CcSEcCtD
Doxepin—ADRA2A—uterus—cervical cancer	0.0027	0.00815	CbGeAlD
Doxepin—Mediastinal disorder—Topotecan—cervical cancer	0.0027	0.0161	CcSEcCtD
Doxepin—Chills—Topotecan—cervical cancer	0.00269	0.0161	CcSEcCtD
Doxepin—ORM1—lymph node—cervical cancer	0.00268	0.00808	CbGeAlD
Doxepin—Alopecia—Topotecan—cervical cancer	0.00265	0.0158	CcSEcCtD
Doxepin—Malnutrition—Topotecan—cervical cancer	0.00261	0.0156	CcSEcCtD
Doxepin—HTR2A—renal system—cervical cancer	0.00258	0.00778	CbGeAlD
Doxepin—Back pain—Topotecan—cervical cancer	0.00252	0.0151	CcSEcCtD
Doxepin—CYP2C9—female reproductive system—cervical cancer	0.00251	0.00756	CbGeAlD
Doxepin—Muscle spasms—Topotecan—cervical cancer	0.00251	0.015	CcSEcCtD
Doxepin—HRH1—female reproductive system—cervical cancer	0.00247	0.00746	CbGeAlD
Doxepin—ADRA2A—female reproductive system—cervical cancer	0.00243	0.00733	CbGeAlD
Doxepin—Ill-defined disorder—Topotecan—cervical cancer	0.00242	0.0145	CcSEcCtD
Doxepin—Anaemia—Topotecan—cervical cancer	0.00241	0.0144	CcSEcCtD
Doxepin—CYP3A4—renal system—cervical cancer	0.00239	0.0072	CbGeAlD
Doxepin—Malaise—Topotecan—cervical cancer	0.00235	0.0141	CcSEcCtD
Doxepin—CYP2D6—renal system—cervical cancer	0.00235	0.00709	CbGeAlD
Doxepin—Leukopenia—Topotecan—cervical cancer	0.00233	0.0139	CcSEcCtD
Doxepin—Cough—Topotecan—cervical cancer	0.00228	0.0136	CcSEcCtD
Doxepin—HTR2B—lymph node—cervical cancer	0.00226	0.00682	CbGeAlD
Doxepin—HRH1—female gonad—cervical cancer	0.00225	0.00679	CbGeAlD
Doxepin—HRH1—vagina—cervical cancer	0.00224	0.00675	CbGeAlD
Doxepin—Chest pain—Topotecan—cervical cancer	0.00222	0.0133	CcSEcCtD
Doxepin—Myalgia—Topotecan—cervical cancer	0.00222	0.0133	CcSEcCtD
Doxepin—Arthralgia—Topotecan—cervical cancer	0.00222	0.0133	CcSEcCtD
Doxepin—ADRA2A—female gonad—cervical cancer	0.00221	0.00667	CbGeAlD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.0022	0.0132	CcSEcCtD
Doxepin—ADRA2A—vagina—cervical cancer	0.0022	0.00663	CbGeAlD
Doxepin—Discomfort—Topotecan—cervical cancer	0.00219	0.0131	CcSEcCtD
Doxepin—Infection—Topotecan—cervical cancer	0.00211	0.0126	CcSEcCtD
Doxepin—Nervous system disorder—Topotecan—cervical cancer	0.00209	0.0125	CcSEcCtD
Doxepin—Thrombocytopenia—Topotecan—cervical cancer	0.00208	0.0125	CcSEcCtD
Doxepin—Skin disorder—Topotecan—cervical cancer	0.00207	0.0124	CcSEcCtD
Doxepin—HTR2A—female reproductive system—cervical cancer	0.00207	0.00623	CbGeAlD
Doxepin—Hyperhidrosis—Topotecan—cervical cancer	0.00206	0.0123	CcSEcCtD
Doxepin—Anorexia—Topotecan—cervical cancer	0.00203	0.0121	CcSEcCtD
Doxepin—SLC6A2—lymph node—cervical cancer	0.00201	0.00606	CbGeAlD
Doxepin—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00194	0.0116	CcSEcCtD
Doxepin—CYP3A4—female reproductive system—cervical cancer	0.00191	0.00577	CbGeAlD
Doxepin—Paraesthesia—Topotecan—cervical cancer	0.00191	0.0114	CcSEcCtD
Doxepin—Dyspnoea—Topotecan—cervical cancer	0.0019	0.0113	CcSEcCtD
Doxepin—CYP2D6—female reproductive system—cervical cancer	0.00188	0.00567	CbGeAlD
Doxepin—Dyspepsia—Topotecan—cervical cancer	0.00187	0.0112	CcSEcCtD
Doxepin—HTR2A—vagina—cervical cancer	0.00187	0.00563	CbGeAlD
Doxepin—Decreased appetite—Topotecan—cervical cancer	0.00185	0.0111	CcSEcCtD
Doxepin—Gastrointestinal disorder—Topotecan—cervical cancer	0.00184	0.011	CcSEcCtD
Doxepin—Fatigue—Topotecan—cervical cancer	0.00183	0.011	CcSEcCtD
Doxepin—ABCB1—epithelium—cervical cancer	0.00182	0.0055	CbGeAlD
Doxepin—Pain—Topotecan—cervical cancer	0.00182	0.0109	CcSEcCtD
Doxepin—Constipation—Topotecan—cervical cancer	0.00182	0.0109	CcSEcCtD
Doxepin—ABCB1—uterine cervix—cervical cancer	0.00181	0.00545	CbGeAlD
Doxepin—KCNH2—lymph node—cervical cancer	0.0018	0.00544	CbGeAlD
Doxepin—ADRA2C—lymph node—cervical cancer	0.00178	0.00537	CbGeAlD
Doxepin—Feeling abnormal—Topotecan—cervical cancer	0.00175	0.0105	CcSEcCtD
Doxepin—Gastrointestinal pain—Topotecan—cervical cancer	0.00174	0.0104	CcSEcCtD
Doxepin—ABCB1—decidua—cervical cancer	0.00172	0.00519	CbGeAlD
Doxepin—CYP2D6—female gonad—cervical cancer	0.00171	0.00516	CbGeAlD
Doxepin—Urticaria—Topotecan—cervical cancer	0.00169	0.0101	CcSEcCtD
Doxepin—ABCB1—renal system—cervical cancer	0.00169	0.0051	CbGeAlD
Doxepin—Abdominal pain—Topotecan—cervical cancer	0.00168	0.0101	CcSEcCtD
Doxepin—Body temperature increased—Topotecan—cervical cancer	0.00168	0.0101	CcSEcCtD
Doxepin—ABCB1—endometrium—cervical cancer	0.00163	0.00493	CbGeAlD
Doxepin—ABCB1—mammalian vulva—cervical cancer	0.00158	0.00477	CbGeAlD
Doxepin—Hypersensitivity—Topotecan—cervical cancer	0.00157	0.00937	CcSEcCtD
Doxepin—Asthenia—Topotecan—cervical cancer	0.00153	0.00912	CcSEcCtD
Doxepin—ABCB1—uterus—cervical cancer	0.00151	0.00454	CbGeAlD
Doxepin—Pruritus—Topotecan—cervical cancer	0.00151	0.009	CcSEcCtD
Doxepin—Diarrhoea—Topotecan—cervical cancer	0.00146	0.0087	CcSEcCtD
Doxepin—HRH1—lymph node—cervical cancer	0.00145	0.00436	CbGeAlD
Doxepin—ADRA2A—lymph node—cervical cancer	0.00142	0.00429	CbGeAlD
Doxepin—Dizziness—Topotecan—cervical cancer	0.00141	0.00841	CcSEcCtD
Doxepin—ABCB1—female reproductive system—cervical cancer	0.00135	0.00408	CbGeAlD
Doxepin—Vomiting—Topotecan—cervical cancer	0.00135	0.00808	CcSEcCtD
Doxepin—Rash—Topotecan—cervical cancer	0.00134	0.00802	CcSEcCtD
Doxepin—Dermatitis—Topotecan—cervical cancer	0.00134	0.00801	CcSEcCtD
Doxepin—Headache—Topotecan—cervical cancer	0.00133	0.00797	CcSEcCtD
Doxepin—Nausea—Topotecan—cervical cancer	0.00126	0.00755	CcSEcCtD
Doxepin—ABCB1—female gonad—cervical cancer	0.00123	0.00371	CbGeAlD
Doxepin—ABCB1—vagina—cervical cancer	0.00122	0.00369	CbGeAlD
Doxepin—ABCB1—lymph node—cervical cancer	0.000792	0.00239	CbGeAlD
Doxepin—CHRM2—Signaling Pathways—WNT5A—cervical cancer	0.000107	0.000339	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	0.000106	0.000338	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CA9—cervical cancer	0.000104	0.000331	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—FGFR3—cervical cancer	0.000102	0.000326	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CA9—cervical cancer	0.000102	0.000324	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—NOTCH2—cervical cancer	0.000101	0.000322	CbGpPWpGaD
Doxepin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.0001	0.000319	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	9.88e-05	0.000314	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—HES1—cervical cancer	9.77e-05	0.000311	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—NOTCH1—cervical cancer	9.62e-05	0.000306	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CA9—cervical cancer	9.59e-05	0.000305	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CA9—cervical cancer	9.51e-05	0.000302	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—MTOR—cervical cancer	9.29e-05	0.000295	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HES1—cervical cancer	9.22e-05	0.000293	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	9.14e-05	0.00029	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HES1—cervical cancer	8.92e-05	0.000283	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HES1—cervical cancer	8.83e-05	0.000281	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	8.82e-05	0.00028	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	8.78e-05	0.000279	CbGpPWpGaD
Doxepin—HRH2—Signaling by GPCR—EGFR—cervical cancer	8.57e-05	0.000272	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TERT—cervical cancer	8.56e-05	0.000272	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—CASP3—cervical cancer	8.55e-05	0.000272	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	8.54e-05	0.000271	CbGpPWpGaD
Doxepin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	8.43e-05	0.000268	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	8.4e-05	0.000267	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HES1—cervical cancer	8.3e-05	0.000264	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—CTNNB1—cervical cancer	8.24e-05	0.000262	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CA9—cervical cancer	8.13e-05	0.000258	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TERT—cervical cancer	8.08e-05	0.000257	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—FGFR3—cervical cancer	7.86e-05	0.00025	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TERT—cervical cancer	7.81e-05	0.000248	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NOTCH2—cervical cancer	7.74e-05	0.000246	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TERT—cervical cancer	7.73e-05	0.000246	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	7.62e-05	0.000242	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NOTCH2—cervical cancer	7.6e-05	0.000242	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NOTCH2—cervical cancer	7.58e-05	0.000241	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NOTCH2—cervical cancer	7.56e-05	0.00024	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HES1—cervical cancer	7.49e-05	0.000238	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NOTCH2—cervical cancer	7.48e-05	0.000238	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	7.46e-05	0.000237	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—FGFR3—cervical cancer	7.41e-05	0.000236	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—NOTCH1—cervical cancer	7.38e-05	0.000234	CbGpPWpGaD
Doxepin—ADRA2B—Hemostasis—TP53—cervical cancer	7.37e-05	0.000234	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—MTHFR—cervical cancer	7.35e-05	0.000234	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TERT—cervical cancer	7.27e-05	0.000231	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HES1—cervical cancer	7.23e-05	0.00023	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—MTOR—cervical cancer	7.21e-05	0.000229	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HES1—cervical cancer	7.2e-05	0.000229	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—STAT3—cervical cancer	7.18e-05	0.000228	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—FGFR3—cervical cancer	7.17e-05	0.000228	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—FGFR3—cervical cancer	7.1e-05	0.000226	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HES1—cervical cancer	7e-05	0.000222	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—NOTCH1—cervical cancer	6.96e-05	0.000221	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	6.93e-05	0.00022	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HES1—cervical cancer	6.89e-05	0.000219	CbGpPWpGaD
Doxepin—ADRA2C—Hemostasis—TP53—cervical cancer	6.89e-05	0.000219	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	6.73e-05	0.000214	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	6.67e-05	0.000212	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—NOTCH1—cervical cancer	6.66e-05	0.000212	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—CASP3—cervical cancer	6.63e-05	0.000211	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—EGFR—cervical cancer	6.57e-05	0.000209	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TERT—cervical cancer	6.57e-05	0.000209	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—EGFR—cervical cancer	6.53e-05	0.000207	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—MTHFR—cervical cancer	6.51e-05	0.000207	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—CTNNB1—cervical cancer	6.39e-05	0.000203	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HES1—cervical cancer	6.35e-05	0.000202	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TERT—cervical cancer	6.34e-05	0.000201	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TERT—cervical cancer	6.3e-05	0.0002	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CA9—cervical cancer	6.27e-05	0.000199	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	6.26e-05	0.000199	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—HES1—cervical cancer	6.25e-05	0.000199	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HES1—cervical cancer	6.23e-05	0.000198	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HES1—cervical cancer	6.21e-05	0.000198	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—EGFR—cervical cancer	6.2e-05	0.000197	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HES1—cervical cancer	6.19e-05	0.000197	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HES1—cervical cancer	6.13e-05	0.000195	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TERT—cervical cancer	6.13e-05	0.000195	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HES1—cervical cancer	6.12e-05	0.000194	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TERT—cervical cancer	6.04e-05	0.000192	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	6.02e-05	0.000191	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—EGFR—cervical cancer	6e-05	0.000191	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—MTHFR—cervical cancer	5.97e-05	0.00019	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—EGFR—cervical cancer	5.94e-05	0.000189	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—FGFR3—cervical cancer	5.82e-05	0.000185	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—FGFR3—cervical cancer	5.79e-05	0.000184	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HES1—cervical cancer	5.68e-05	0.000181	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	5.66e-05	0.00018	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	5.63e-05	0.000179	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—TP53—cervical cancer	5.59e-05	0.000178	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	5.58e-05	0.000177	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—STAT3—cervical cancer	5.57e-05	0.000177	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TERT—cervical cancer	5.56e-05	0.000177	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	5.54e-05	0.000176	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MTOR—cervical cancer	5.53e-05	0.000176	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—TP53—cervical cancer	5.48e-05	0.000174	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TERT—cervical cancer	5.47e-05	0.000174	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TERT—cervical cancer	5.46e-05	0.000174	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	5.46e-05	0.000174	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TERT—cervical cancer	5.45e-05	0.000173	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	5.43e-05	0.000173	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TERT—cervical cancer	5.43e-05	0.000173	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TERT—cervical cancer	5.38e-05	0.000171	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TERT—cervical cancer	5.36e-05	0.00017	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	5.28e-05	0.000168	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MTOR—cervical cancer	5.21e-05	0.000166	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	5.2e-05	0.000165	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—FGFR3—cervical cancer	5.11e-05	0.000162	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CASP3—cervical cancer	5.08e-05	0.000162	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—EGFR—cervical cancer	5.06e-05	0.000161	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MTOR—cervical cancer	5.05e-05	0.00016	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	5.04e-05	0.00016	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—FGFR3—cervical cancer	5.02e-05	0.00016	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—FGFR3—cervical cancer	5.01e-05	0.000159	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—FGFR3—cervical cancer	5e-05	0.000159	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MTOR—cervical cancer	4.99e-05	0.000159	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—FGFR3—cervical cancer	4.98e-05	0.000158	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TERT—cervical cancer	4.98e-05	0.000158	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—FGFR3—cervical cancer	4.93e-05	0.000157	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	4.92e-05	0.000156	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CTNNB1—cervical cancer	4.9e-05	0.000156	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—EGFR—cervical cancer	4.86e-05	0.000155	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—EGFR—cervical cancer	4.84e-05	0.000154	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CASP3—cervical cancer	4.8e-05	0.000152	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NOTCH1—cervical cancer	4.79e-05	0.000152	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	4.72e-05	0.00015	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	4.71e-05	0.00015	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NOTCH1—cervical cancer	4.71e-05	0.00015	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MTOR—cervical cancer	4.69e-05	0.000149	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NOTCH1—cervical cancer	4.69e-05	0.000149	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NOTCH1—cervical cancer	4.68e-05	0.000149	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CASP3—cervical cancer	4.64e-05	0.000147	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	4.63e-05	0.000147	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NOTCH1—cervical cancer	4.63e-05	0.000147	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CTNNB1—cervical cancer	4.62e-05	0.000147	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	4.62e-05	0.000147	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CASP3—cervical cancer	4.59e-05	0.000146	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	4.57e-05	0.000145	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	4.47e-05	0.000142	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CTNNB1—cervical cancer	4.43e-05	0.000141	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CASP3—cervical cancer	4.32e-05	0.000137	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	4.29e-05	0.000136	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—STAT3—cervical cancer	4.27e-05	0.000136	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—EGFR—cervical cancer	4.27e-05	0.000136	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TP53—cervical cancer	4.25e-05	0.000135	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MTOR—cervical cancer	4.24e-05	0.000135	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—MTHFR—cervical cancer	4.23e-05	0.000135	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—EGFR—cervical cancer	4.2e-05	0.000134	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—EGFR—cervical cancer	4.19e-05	0.000133	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—EGFR—cervical cancer	4.18e-05	0.000133	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—EGFR—cervical cancer	4.17e-05	0.000132	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	4.16e-05	0.000132	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—MTHFR—cervical cancer	4.13e-05	0.000131	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—EGFR—cervical cancer	4.13e-05	0.000131	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	4.12e-05	0.000131	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MTOR—cervical cancer	4.09e-05	0.00013	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MTOR—cervical cancer	4.07e-05	0.000129	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—STAT3—cervical cancer	4.03e-05	0.000128	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MTOR—cervical cancer	3.96e-05	0.000126	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—STAT3—cervical cancer	3.9e-05	0.000124	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CASP3—cervical cancer	3.9e-05	0.000124	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MTOR—cervical cancer	3.9e-05	0.000124	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—MTHFR—cervical cancer	3.89e-05	0.000124	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—EGFR—cervical cancer	3.88e-05	0.000123	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—MTHFR—cervical cancer	3.86e-05	0.000123	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—STAT3—cervical cancer	3.86e-05	0.000123	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	3.82e-05	0.000122	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CASP3—cervical cancer	3.76e-05	0.00012	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	3.76e-05	0.000119	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CASP3—cervical cancer	3.74e-05	0.000119	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—EGFR—cervical cancer	3.66e-05	0.000116	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CASP3—cervical cancer	3.64e-05	0.000116	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—STAT3—cervical cancer	3.63e-05	0.000115	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	3.63e-05	0.000115	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	3.61e-05	0.000115	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MTOR—cervical cancer	3.59e-05	0.000114	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CASP3—cervical cancer	3.58e-05	0.000114	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—EGFR—cervical cancer	3.54e-05	0.000113	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MTOR—cervical cancer	3.53e-05	0.000112	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MTOR—cervical cancer	3.53e-05	0.000112	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MTOR—cervical cancer	3.52e-05	0.000112	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	3.51e-05	0.000112	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—EGFR—cervical cancer	3.51e-05	0.000111	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MTOR—cervical cancer	3.5e-05	0.000111	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MTOR—cervical cancer	3.47e-05	0.00011	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MTOR—cervical cancer	3.46e-05	0.00011	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	3.45e-05	0.00011	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CASP3—cervical cancer	3.3e-05	0.000105	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MTHFR—cervical cancer	3.3e-05	0.000105	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—EGFR—cervical cancer	3.3e-05	0.000105	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—STAT3—cervical cancer	3.28e-05	0.000104	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—cervical cancer	3.26e-05	0.000104	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CASP3—cervical cancer	3.25e-05	0.000103	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CASP3—cervical cancer	3.24e-05	0.000103	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CASP3—cervical cancer	3.23e-05	0.000103	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CASP3—cervical cancer	3.22e-05	0.000102	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MTOR—cervical cancer	3.22e-05	0.000102	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CASP3—cervical cancer	3.19e-05	0.000101	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CTNNB1—cervical cancer	3.18e-05	0.000101	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CASP3—cervical cancer	3.18e-05	0.000101	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—STAT3—cervical cancer	3.16e-05	0.0001	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—STAT3—cervical cancer	3.15e-05	0.0001	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	3.13e-05	9.96e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CTNNB1—cervical cancer	3.13e-05	9.94e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CTNNB1—cervical cancer	3.12e-05	9.91e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CTNNB1—cervical cancer	3.11e-05	9.87e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CTNNB1—cervical cancer	3.08e-05	9.78e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—cervical cancer	3.07e-05	9.77e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	3.07e-05	9.75e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—STAT3—cervical cancer	3.06e-05	9.72e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—STAT3—cervical cancer	3.01e-05	9.57e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EGFR—cervical cancer	2.98e-05	9.46e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—cervical cancer	2.98e-05	9.46e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP3—cervical cancer	2.96e-05	9.4e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—cervical cancer	2.94e-05	9.36e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EGFR—cervical cancer	2.87e-05	9.13e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EGFR—cervical cancer	2.86e-05	9.09e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	2.85e-05	9.06e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EGFR—cervical cancer	2.78e-05	8.84e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—STAT3—cervical cancer	2.78e-05	8.82e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—cervical cancer	2.77e-05	8.8e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EGFR—cervical cancer	2.74e-05	8.7e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—STAT3—cervical cancer	2.73e-05	8.68e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—STAT3—cervical cancer	2.73e-05	8.66e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—STAT3—cervical cancer	2.72e-05	8.64e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—STAT3—cervical cancer	2.71e-05	8.61e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—STAT3—cervical cancer	2.68e-05	8.52e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—STAT3—cervical cancer	2.67e-05	8.5e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MTHFR—cervical cancer	2.54e-05	8.09e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EGFR—cervical cancer	2.52e-05	8.02e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—cervical cancer	2.5e-05	7.94e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—STAT3—cervical cancer	2.49e-05	7.9e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EGFR—cervical cancer	2.48e-05	7.89e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EGFR—cervical cancer	2.48e-05	7.87e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EGFR—cervical cancer	2.47e-05	7.85e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EGFR—cervical cancer	2.46e-05	7.82e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EGFR—cervical cancer	2.44e-05	7.75e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EGFR—cervical cancer	2.43e-05	7.73e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—cervical cancer	2.41e-05	7.67e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—cervical cancer	2.4e-05	7.63e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—cervical cancer	2.33e-05	7.42e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—cervical cancer	2.3e-05	7.3e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EGFR—cervical cancer	2.26e-05	7.18e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—cervical cancer	2.12e-05	6.73e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—cervical cancer	2.08e-05	6.62e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—cervical cancer	2.08e-05	6.61e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—cervical cancer	2.07e-05	6.59e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—cervical cancer	2.07e-05	6.57e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—cervical cancer	2.05e-05	6.5e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—cervical cancer	2.04e-05	6.49e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—cervical cancer	1.9e-05	6.03e-05	CbGpPWpGaD
